As of 2026-03-18, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 11.0x | 8.5x |
| Forward P/E multiples | 10.9x - 15.8x | 14.2x |
| Fair Price | (24.28) - (24.46) | (25.33) |
| Upside | -4515.1% - -4547.2% | -4705.7% |
| Date | EV/EBITDA |